← Back to Patent Explorer
US4843122A Expired / Lapsed US ⏱️ 0.0 years remaining

Detectable molecules, method of preparation and use

Assignee: Enzo Diagnostics Inc
•
Filing: 1987-04-28
•
Granted: 1989-06-27
•
Expires: 2007-04-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A detectable molecule of the formula A3-(-X-R1-E-Detb)m where A3 is A2 or a polymer, where A3 has at least one modifiable reactive group selected from the group consisting of amino, hydroxy, cis .OH, halides, aryl, imidazoyl, carbonyl, carboxy, thiol or a residue comprising an activated carbon; -X- is selected from the group consisting of <IMAGE> <IMAGE> <IMAGE> <IMAGE> +TR <IMAGE> a C1-C10 branched or unbranched alkyl or aralkyl, which may be substituted by -OH; -Y- is a direct bond to -E-, or -Y- is -E-R2- where R2 is a C1-C10 branched or unbranched alkyl; Za is chlorine, bromine or iodine; E is O, NH or an acylic divalent sulfur atom; Detb is a chemical moiety capable of being detected, preferably comprising biotin or a metal chelator of the formula: <IMAGE> or the 4-hydroxy or acyloxy derivative thereof, where R3 is C1-C4 alkyl or CH2COOM, M is the same or different and selected from the group consisting of hydrogen, a metal or non-metal cation or is C1-C10 alkyl, aryl or aralkyl; and m is an integer from 1 to the total number of modified reactive groups on A3. The detectable molecules are useful in in vitro or in vivo assays or therapy.

Inventors

  • 👤 Jannis G. Stavrianopoulos

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 14:57
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/10; A61K51/1093; A61K51/0497; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/533; G01N33/543; G01N33/551; G01N33/553

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 102 words
A compound of the formula: ##STR52## where A 3 is A 2 or a biopolymer selected from the group consisting of an oligo- or polynucleotide, oligo- or polysaccharide, oligo- or polypeptide or a synthetic polymer, each of A 2 and said oligo-or polynucleotide, oligo- or polysaccharide, oligo- or polypeptide or synthetic polymer having m modifiable reactive groups consisting of amino, hydroxy, 1,2-cis diOH, halide, aryl, imidazoyl, carbonyl, carboxyl, thiol or a residue comprising an activated carbon; Z b is fluorine, chlorine or bromine; and m is an integer from 1 to the total number of modifiable reactive groups on A 3 .
Claim 2
Dependent Claim 102 words
A compound of the formula: ##STR52## where A 3 is A 2 or a biopolymer selected from the group consisting of an oligo- or polynucleotide, oligo- or polysaccharide, oligo- or polypeptide or a synthetic polymer, each of A 2 and said oligo-or polynucleotide, oligo- or polysaccharide, oligo- or polypeptide or synthetic polymer having m modifiable reactive groups consisting of amino, hydroxy, 1,2-cis diOH, halide, aryl, imidazoyl, carbonyl, carboxyl, thiol or a residue comprising an activated carbon; Z b is fluorine, chlorine or bromine; and m is an integer from 1 to the total number of modifiable reactive groups on A 3 .
Claim 3
Dependent Claim 18 words
The compound of claim 1 wherein the biopolymer is a polypeptide which contains tyrosine, histidine or amino residues.
Claim 4
Dependent Claim 15 words
The compound of claim 1 wherein the biopolymer is a polynucleotide which contains guanine bases.
Claim 5
Dependent Claim 10 words
The compound of claim 3 wherein the polynucleotide is DNA.
Claim 6
Dependent Claim 14 words
The compound of claim 1 wherein A 3 is a polypeptide or a polysaccharide.
Claim 7
Dependent Claim 17 words
The compound of claim 1 wherein said polypeptide is a structural protein, an immunoglobulin, or an enzyme.
Claim 8
Dependent Claim 12 words
The compound of claim 6 wherein said immunoglobulin is a monoclonal antibody.
Claim 9
Dependent Claim 45 words
The compound of claim 1 wherein said activated carbon in said modifiable group is present in a tyrosine or histidine residue of a polypeptide, or on a guanine, cytidine or inosine base of a polynucleotide, and is capable of covalent coupling to a diazonium compound.
Claim 10
Dependent Claim 10 words
The compound of claim 8 wherein said base is guanine.
Claim 11
Dependent Claim 11 words
The compound of claim 1 wherein A 3 is a polynucleotide.
Claim 12
Dependent Claim 12 words
The compound of claim 10 wherein said polynucleotide is RNA or DNA.
Claim 13
Dependent Claim 10 words
The compound of claim 1 wherein Z b is chlorine.
Claim 14
Dependent Claim 13 words
The compound of claim 5 wherein said reactive group is a tyrosine residue.

References Cited (Backward Citations)

GB2019408A Cited
US4374120A Cited
EP0063879A2 Cited
US4563419A Cited
EP0117440A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-26 1992-12-26 1993-06-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-26 1996-12-26 1997-06-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-26 2000-12-26 2001-06-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag